Skip to content

Transcranial Direct Current Stimulation in Clinical Setting to Reduce Pain in Older Workers

Observation et Analyse Des Effets de la Stimulation transcrânienne à Courant Continu en Milieu Clinique Pour Soulager la Douleur Chronique Chez Les Travailleurs Vieillissants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05370833
Enrollment
24
Registered
2022-05-12
Start date
2022-05-15
Completion date
2024-05-30
Last updated
2023-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Chronic Pain

Keywords

transcranial direct current stimulation, physical therapy, work retention

Brief summary

Chronic pain is one of the main factors influencing workers' retention at work. Considering that the prevalence of suffering from chronic pain increases with age, older workers are most likely to be absent from work because of their pain. Transcranial direct current stimulation (tDCS) is a treatment option to reduce chronic pain. This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).

Detailed description

Chronic pain affects many spheres of the lives of affected individuals and those around them. In Canada, the prevalence of chronic pain is estimated at 15% of adults aged 18 and over. Among seniors, the prevalence of this health problem can reach up to 50% and affect one in two seniors. Chronic pain is one of the leading causes of work disability. In this context, pain reduction remains one of the most effective methods to enable the worker to stay at work. Considering the aging Quebec population, labor needs and the average retirement age which is increasingly postponed, it becomes crucial to take an interest in aging workers and their continued employment. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation method that has shown promise in reducing chronic pain. Recently, several research teams have shown that tDCS has beneficial effects on pain, physical function and social participation in seniors. Despite all these recent advances, very few studies have focused on optimizing tDCS treatment modalities and no studies have focused on the impact of tDCS on return to work or retention. The vast majority of studies using tDCS to reduce pain give one tDCS session per day for 5 consecutive days. This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).

Interventions

DEVICEtranscranial direct current stimulation

Anodal, 2mA, tDCS session applied on M1 for 20 minutes.

Sponsors

CISSS Abitibi-Témiscamingue
CollaboratorUNKNOWN
Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
56 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* To be more than 55 years old * To have chronic pain * To have employment relationship * To have pain that interferes with work tasks

Exclusion criteria

\- tDCS contraindications (epilepsy, metallic implant in the head, pacemaker, cochlear implant)

Design outcomes

Primary

MeasureTime frameDescription
Central sensitizationBefore tDCScentral sensitization inventory
AnxietyBefore tDCSBeck anxiety inventory
DepressionBefore tDCSBeck depression inventory
Impression of change1 weekPatient Global impression of change
Pain intensityBefore tDCS0-10 Numerical rating scale
DisabilityBefore tDCSPain Disability Index
Work role functioningBefore tDCSWork Role Functioning Questionnaire
Physical FunctioningBefore tDCSBrief Pain Inventory

Secondary

MeasureTime frameDescription
Securitythrough study completion, about 2 yearsFeasibility of the study
Interventionthrough study completion, about 2 yearsFeasibility of the study
Recruitmentthrough study completion, about 2 yearsFeasibility of the study

Countries

Canada

Contacts

Primary ContactGuillaume Leonard, PhD
guillaume.leonard2@usherbrooke.ca819-780-2220

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026